The findings of our research indicate a significant upregulation of TNFRSF19 in glioma tissues as compared to non-tumor tissues across three cohorts, a result that was further validated in an external set through immunohistochemical analysis (P < 0.05, Fig. 5A). Here, TNFRSF19 is linked to central nervous system cancer.